- Home
- HUMA vs NVCT Comparison
HUMA vs NVCT Comparison
Compare HUMA & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUMA | NVCT |
|---|---|---|
| Founded | 2004 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.0M | 197.0M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | HUMA | NVCT |
|---|---|---|
| Price | $1.09 | $7.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $10.13 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 4.2M | 94.5K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,571,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $731.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.06 | $4.44 |
| 52 Week High | $6.77 | $11.52 |
Technical Indicators
Market Signals| Indicator | HUMA | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 70.05 |
| Support Level | $1.21 | $6.47 |
| Resistance Level | $1.32 | $7.77 |
| Average True Range (ATR) | 0.08 | 0.40 |
| MACD | -0.00 | 0.13 |
| Stochastic Oscillator | 7.78 | 89.75 |
Price Performance
Historical ComparisonAbout HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.